Ocular Implants Market

Ocular Implants Market By Type (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Orbital Implants, And Ocular Prosthesis) By Material (Biodegradable And Non-Biodegradable), By Application (Cataract, Glaucoma Surgery, Oculoplasty, Drug Delivery, Macular Degeneration, And Others), By End-User (Hospitals, Eye Speciality Clinics, And Ambulatory Surgical Centres) and by geography is estimated to register a growth at a remarkable CAGR forecast during 2022-2027 owing to upsurge in the cases of cataract, glaucoma, presbyopia and myopia, rise in the geriatric population along with constant technological advancements in product design.

 

The Global Ocular Implants Market was valued at USD 11.26 billion in 2021, growing at a CAGR of 5.90% during the forecast period from 2022 to 2027 to reach USD 15.87 billion by 2027. The Ocular Implants market is slated to witness increasing revenue owing to factors such as a rise in the cases of eye disorders like glaucoma, cataract, presbyopia, and myopia, a rising population of geriatric people around the world, along with the latest technological advancements to further enhance product safety and biocompatibility is expected to result in appreciable revenue growth in the Ocular Implants market during the forecast period (2022-2027).

Ocular Implants Market Dynamics:

One of the noteworthy drivers of the Ocular Implants market is the rise in the prevalence of eye disorders such as cataract, glaucoma, presbyopia, and myopia. For instance, according to the World Health Organization (2021), the prevalence of population having near or distance vision impairment stands at a staggering figure of 2.2 billion globally, in which almost half of the affected people could have prevented vision impairment, or the cases have not yet been addressed. According to the same source, the prevalence rate of unaddressed cataracts and glaucoma in the year 2020 were 94 million and 7.7 million respectively.  The number of refractive errors such as myopia and presbyopia is also said to increase in the upcoming years. For example, as per the International Myopia Institute (2022), 30% of the world is currently myopic and by 2050, the number of myopic people is said to grow to 50%, accounting for five billion. The aforementioned source further stated that myopia is more prevalent in East and South East Asia where countries such as South Korea, China, and Japan have a prevalence of 80% to 90%. In the case of presbyopia, as per the data cited by the World Health Organization in their World Report on Vision (2019), presbyopia accounted for approximately 1.8 billion cases across the globe in the year 2018.

 

Additionally, the increasing cases of eye disorders are further linked to the rise in the geriatric population around the world, driving the ocular implant market. According to the National Eye Institute (2022), refractive errors such as presbyopia affect 100% of the population in people aged above the range of 55-65 years. Thus, the rising prevalence of eye disorders and refractive errors such as myopia and presbyopia are expected to drive the demand for ocular implants, eventually leading to the global ocular implants market growth during the forecast period (2022-2027).

 

Another prominent factor responsible for the growth of the Ocular Implants Market is the constant technological developments taking place in the Ocular Implants market for enhanced product design, and for increasing its safety and biocompatibility. For instance, in September 2020, Alcon Inc., announced the launch of Aero SOF IQ Vivity; delivering an extended range of vision through X-Wave Technology which also received FDA approval, during a pilot phase. In January 2021, Alcon finally released the product for use in commercial markets. In a similar development, in September 2020, Hoya Surgical Optics, a part of Hoya Corporation announced the global launch of the CLEAR log, in Singapore. It is a specialized next-generation technology application designed to analyze the clinical results and outcomes of cataract and Refractive Lens Exchange Surgery.

 

However, due to the side effects associated with cataract and glaucoma surgeries which can result in long-term hindrances to vision, a lack of skilled workforce along with low rates of diagnosis may act as restraining factors for the Ocular Implants market.

 

The Ocular Implants market reported a short period of a setback in market growth due to the implementation of lockdown as necessary measures to break the chain of the COVID-19 infection transmission. The COVID-19 pandemic resulted in the massive reorganization of healthcare services and carrying out medical procedures. Many countries segregated medical procedures based on the need for urgent medical care to streamline the workflow during the COVID-19 crisis and saw various medical procedures considered elective being suspended. For instance, in March 2020, the American Academy of Ophthalmology (AAO) recommended ophthalmologists to stop all routine activities and restrict their treatment only to urgent and emergent cases; the AAO also recommended that clinical activities could be performed with continued caution in compliance with local regulations. Furthermore, the procedures of intra-ocular surgeries decreased as it became difficult to procure ocular implants during the lockdown period. This led to a decrease in product demand from regular levels. However, the resumption of activities across industries including the healthcare sector has been uplifting the Ocular implants market and will drive the growth during the forecast period from 2022-2027.

Ocular Implants Market Segment Analysis:

Ocular Implants Market by Type (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Orbital Implants, and Ocular Prosthesis), Material (Biodegradable and Non-biodegradable), Application (Cataract, Glaucoma Surgery, Oculoplasty, Drug Delivery, Macular Degeneration, and Others), End-user (Hospitals, Eye Speciality Clinics, Ambulatory Surgical Centres), Geography (North-America, Europe, Asia-Pacific, Rest of the World).

 

Based on the Application segment of the Ocular implants market, the cataracts category is projected to register significant growth in revenue in the Ocular implants market during the forecast period (2022-2027). This can be ascribed to an increase in the prevalence of cataract cases all around the world, which lead to serious consequences like total vision impairment and moderate to severe visual impairment (MSVI). As per reports by the Prevent Blindness Organization (2021), cataract was the highest contributing factor to total vision impairment worldwide, responsible for 20 million cataract blindness cases across all age groups in the year 2018. Risks of cataract and blindness also increase with several factors, the strongest factor being age. For example, according to the Journal of Investigative Ophthalmology and Visual Sciences (2021), in the year 2020, 15.2 million people aged 50 and above were blind, due to cataract. According to the same source, the rates for cataract-caused blindness had increased by 29.7% in 2020 from 2000, where age-standardized prevalence for cataract blindness had decreased in males to a large extent as compared to females (31.8% and 24.8%).

 

Therefore, considering the growing demand for this cataract-related ocular implants, various new products are being launched in the market with technological advancements. For example, in April 2022, STAAR SURGICAL announced the launch of EVO Vision Implantable Collamer Lens at the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington D.C. The implant is used for correcting cataract and other visual refractive errors and is FDA approved, having a 99.4% success rate among patients. Another example of one of the best ocular implants is the one launched by Alcon, known as AcrySof PanOptix. In August 2019, Alcon gained FDA approval for its AcrySof PanOptix Trifocal lens which is the first and only Trifocal lens in the U.S. Due to such a huge prevalence of cataract blindness and MSVIs, this segment of the ocular implants sector is expected to grow significantly during the given forecast period (2022-2027).

North America is expected to dominate the overall Ocular Implants Market:

Among all the regions, North America is expected to lead in revenue generation in the global Ocular Implants market. This can be ascribed to the growing prevalence of eye disorders and refractive errors such as cataract, glaucoma, myopia, presbyopia, etc. In addition to a large patient pool associated with refractive errors in the North America region, high consumer awareness, new market launches and the presence of a highly potent market in terms of product development are also some key factors driving the growth of the North America Ocular Implants Market. According to the Centre for Disease Prevention and Control (2020), in the year 2020, approximately 12 million people aged 40 years and above in the United States have vision impairment, including 1 million who are blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive errors. Due to the presence of a large patient pool in the United States, many ocular implants are getting FDA approvals for their commercial use in markets. For instance, in March 2020, Allergan, which is a part of a U.S based multinational company AbbVie, received FDA approval for its product DURYSTA, which is used for the reduction of Intra-ocular pressure in patients suffering from open-angle glaucoma or ocular hypertension.

 

As per the Canadian Association of Optometrists, it is estimated that 30 percent of the Canadian population is myopic. In addition to its increased prevalence in Canada, myopia is occurring at earlier ages and progressing at rates faster than seen in previous generations. Additionally, as per the Canadian Health Measures Survey (2020), from 2016 to 2019, 50.4% of adults aged 40 to 64 indicated they had frequent eye check-ups in the past year, compared with 71.6% of seniors aged 65 to 79. Due to these staggering numbers, big key players in the ocular implants market are launching products with the latest technological developments. For example, in February 2021, Alcon Canada launched AutonoMe preloaded intraocular lens delivery system that provides easy, intuitive control for precise insertion during cataract surgery. It possesses new proprietary bio-Material with advanced manufacturing technology for exceptional clarity and vision for Clareon intraocular lens.

 

Therefore, the presence of a large patient population base with eye disorders and refractive errors, coupled with a rise in technological advancements for increasing the safety and biocompatibility of implants is expected to bolster the growth of the Ocular implants market in the North American region during the forecast period.

Ocular Implants Market Key Players:

Some of the key market players operating in the Ocular Implants market include Alcon Inc., Johnson & Johnson Services Inc., Bausch Health Companies Inc., ZEISS International, STAAR SURGICAL, Hoya Corporation, Glaukos Corporation, Second Sight, AbbVie Inc., Innolens, SAV-IOL SA, Morcher, Ophtec BV, Novartis International AG, NVision Eye Centres, iSTAR Medical, SMR Ophthalmic Pvt Ltd., Gulden Ophthalmics, MED-EL Medical Electronics, Aetna Inc. and others.

Recent Developmental Activities in the Ocular Implants Market:

  • In April 2022, STAAR SURGICAL announced the launch of EVO Vision Implantable Collamer Lens at the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington D.C.
  • In November 2021, Alcon Inc. took over Invantis Inc., which specializes in glaucoma ocular devices that are micro-invasive, in California to expand its glaucoma surgical implants segment. 
  • In May 2020, Bausch+Lomb, a part of Bosch Health Companies Inc., announced the European launch of LuxSmart and LuxGood Preloaded Intraocular lenses. Some of the features of these lenses are their monofocal periphery, acrylic hydrophobicity along with UV light protection.

Key Takeaways from the Ocular Implants Market Report Study

  • Market size analysis for current Ocular Implants market size (2021), and market forecast for 5 years (2022-2027)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Ocular Implants market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years.
  • Key companies dominating the global Ocular Implants market.
  • Various opportunities available for the other competitor in the Ocular Implants market space.
  • What are the top performing segments in 2021? How these segments will perform in 2027?
  • Which are the top-performing regions and countries in the current Ocular Implants market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Ocular Implants market growth in the coming future?

Target Audience who can be benefited from this Ocular Implants Market Report Study

  • Ocular Implants providers
  • Research organizations and consulting companies
  • Ocular Implants -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Ocular Implants machines and reagents
  • Various end users who want to know more about the Ocular Implants market and latest technological developments in the Ocular Implants market.

Frequently Asked Questions for Ocular Implants Market:

1. What are Ocular Implants?

Ocular implants are small devices designed to be inserted into the eye, made of medical grade plastic acrylic. Ocular implants form a part of surgical procedures that help in the fixation of cataracts and other vision impairments such as glaucoma, presbyopia, myopia etc. 

 

2. What is the market for Global Ocular Implants?

The Global Ocular Implants Market was valued at USD 11.26 billion in 2021, growing at a CAGR of 5.90% during the forecast period from 2022 to 2027 to reach USD 15.87 billion by 2027.

 

3. What are the drivers for the Global Ocular Implants market?

The Ocular Implants market is expected to grow significantly owing to factors such as a rise in the prevalence of eye disorders such as cataract, glaucoma, presbyopia, myopia, etc. along with the rising geriatric population globally.  The rapidly growing technological advancements taking place in the Ocular Implants market with better technologies for delivering safe and biocompatible implants are further expected to result in appreciable revenue growth in the Ocular Implants market during the given forecast period (2022-2027).

 

4. Who are the key players operating in Global Ocular Implants Market?

Some of the key market players operating in the Ocular Implants market include Alcon, Johnson & Johnson Services Inc., Bausch Health Companies Inc., ZEISS International, STAAR SURGICAL, Hoya Corporation, Glaukos Corporation, Second Sight, AbbVie Inc., Innolens, SAV-IOL SA, Morcher, Ophtec BV, Novartis International AG, NVision Eye Centres, iSTAR Medical, SMR Ophthalmic Pvt Ltd., Gulden Ophthalmics, MED-EL Medical Electronics, Aetna Inc. and others.

 

5. Which region has the highest share in the Ocular Implants market?

North America is expected to dominate the overall Ocular Implants market during the forecast period, 2022 to 2027. This can be ascribed to the presence of a large number of cases having eye disorders such as glaucoma, cataract, presbyopia, and myopia along with the rising geriatric population in the region. In addition, it is a highly potent market in terms of technological developments and launches along with the presence of key market players among other factors in the region.

1. Ocular Implants Market Report Introduction

2. Ocular Implants Market Executive Summary

2.1. Scope of the Study

2.2. Market at Glance

2.3. Competitive Assessment

2.4. Financial Benchmarking

3. Regulatory Analysis

3.1. The United States

3.2. Europe

3.3. Japan

3.4. China

4. Ocular Implants Market Key Factors Analysis

4.1. Ocular Implants Market Drivers

4.1.1. Rise in the cases of eye disorders like cataract, glaucoma, presbyopia, and myopia

4.1.2. The increasing population of geriatric people globally

4.1.3. Technological advancements in product design

4.2. Ocular Implants Market Restraints and Challenges

4.2.1. Side effects associated with surgical procedures and lack of skilled workforce

4.2.2. Low rates of Diagnosis

4.3. Ocular Implants Market Opportunities

4.3.1. Improving Product safety and biocompatibility

5. Ocular Implants Market Porter’s Five Forces Analysis

5.1. Bargaining Power of Suppliers

5.2. Bargaining Power of Consumers

5.3. Threat of New Entrants

5.4. Threat of Substitutes

5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Ocular Implants Market

7. Ocular Implants Market Layout

7.1. By Type:

7.1.1. Intraocular lenses

7.1.2. Corneal Implants

7.1.3. Glaucoma Implants

7.1.4. Orbital Implants

7.1.5. Ocular Prosthesis

7.2. By Material

7.2.1. Biodegradable

7.2.2. Non-biodegradable

7.3. By Application

7.3.1. Cataract

7.3.2. Glaucoma Surgery

7.3.3. Oculoplasty

7.3.4. Drug Delivery

7.3.5. Macular Degeneration

7.3.6. Others

7.4. By End User

7.4.1. Hospitals

7.4.2. Eye Speciality Clinics

7.4.3. Ambulatory Surgical Centres

7.5. By Geography

7.5.1. North America

7.5.1.1. United States Ocular Implants Market in USD million (2019-2027)

7.5.1.2. Canada Ocular Implants Market in USD million (2019-2027)

7.5.1.3. Mexico Ocular Implants Market in USD million (2019-2027)

7.5.2. Europe

7.5.2.1. France Ocular Implants Market in USD million (2019-2027)

7.5.2.2. Germany Ocular Implants Market in USD million (2019-2027)

7.5.2.3. United Kingdom Ocular Implants Market in USD million (2019-2027)

7.5.2.4. Italy Ocular Implants Market in USD million (2019-2027)

7.5.2.5. Spain Ocular Implants Market in USD million (2019-2027)

7.5.2.6. Russia Ocular Implants Market in USD million (2019-2027)

7.5.2.7. Rest of Europe Ocular Implants Market in USD million (2019-2027)

7.5.3. Asia-Pacific

7.5.3.1. China Ocular Implants Market in USD million (2019-2027)

7.5.3.2. Japan Ocular Implants Market in USD million (2019-2027)

7.5.3.3. India Ocular Implants Market in USD million (2019-2027)

7.5.3.4. Australia Ocular Implants Market in USD million (2019-2027)

7.5.3.5. South Korea Ocular Implants Market in USD million (2019-2027)

7.5.3.6. Rest of Asia Pacific Ocular Implants Market in USD million (2019-2027)

7.5.4. Rest of the World (RoW)

7.5.4.1. Middle East Ocular Implants Market in USD million (2019-2027)

7.5.4.2. Africa Ocular Implants Market in USD million (2019-2027)

7.5.4.3. South America Ocular Implants Market in USD million (2019-2027)

8. Ocular Implants Market Global Company Share Analysis – Key 3-5 Companies

9. Ocular Implants Market Company and Product Profiles

9.1. Alcon

9.1.1. Company Overview

9.1.2. Company Snapshot

9.1.3. Financial Overview

9.1.4. Product Listing

9.1.5. Entropy

9.2. Johnson & Johnson Services Inc.

9.2.1. Company Overview

9.2.2. Company Snapshot

9.2.3. Financial Overview

9.2.4. Product Listing

9.2.5. Entropy

9.3. Bausch Health Companies Inc.

9.3.1. Company Overview

9.3.2. Company Snapshot

9.3.3. Financial Overview

9.3.4. Product Listing

9.3.5. Entropy

9.4. ZEISS International

9.4.1. Company Overview

9.4.2. Company Snapshot

9.4.3. Financial Overview

9.4.4. Product Listing

9.4.5. Entropy

9.5. STAAR SURGICAL

9.5.1. Company Overview

9.5.2. Company Snapshot

9.5.3. Financial Overview

9.5.4. Product Listing

9.5.5. Entropy

9.6. F. Hoya Corporation

9.6.1. Company Overview

9.6.2. Company Snapshot

9.6.3. Financial Overview

9.6.4. Product Listing

9.6.5. Entropy

9.7. Glaukos Corporation

9.7.1. Company Overview

9.7.2. Company Snapshot

9.7.3. Financial Overview

9.7.4. Product Listing

9.7.5. Entropy

9.8. Second Sight

9.8.1. Company Overview

9.8.2. Company Snapshot

9.8.3. Financial Overview

9.8.4. Product Listing

9.8.5. Entropy

9.9. AbbVie Inc.

9.9.1. Company Overview

9.9.2. Company Snapshot

9.9.3. Financial Overview

9.9.4. Product Listing

9.9.5. Entropy

9.10. Innolens

9.10.1. Company Overview

9.10.2. Company Snapshot

9.10.3. Financial Overview

9.10.4. Product Listing

9.10.5. Entropy

9.11. SAV- IOL SA

9.11.1. Company Overview

9.11.2. Company Snapshot

9.11.3. Financial Overview

9.11.4. Product Listing

9.11.5. Entropy

9.12. Morcher

9.12.1. Company Overview

9.12.2. Company Snapshot

9.12.3. Financial Overview

9.12.4. Product Listing

9.12.5. Entropy

9.13. Ophtec BV

9.13.1. Company Overview

9.13.2. Company Snapshot

9.13.3. Financial Overview

9.13.4. Product Listing

9.13.5. Entropy

9.14. Novartis International AG

9.14.1. Company Overview

9.14.2. Company Snapshot

9.14.3. Financial Overview

9.14.4. Product Listing

9.14.5. Entropy

9.15. NVision Eye Centres

9.15.1. Company Overview

9.15.2. Company Snapshot

9.15.3. Financial Overview

9.15.4. Product Listing

9.15.5. Entropy

9.16. iSTAR Medical

9.16.1. Company Overview

9.16.2. Company Snapshot

9.16.3. Financial Overview

9.16.4. Product Listing

9.16.5. Entropy

9.17. SMR Ophthalmic Pvt Ltd.

9.17.1. Company Overview

9.17.2. Company Snapshot

9.17.3. Financial Overview

9.17.4. Product Listing

9.17.5. Entropy

9.18. Gulden Ophthalmics

9.18.1. Company Overview

9.18.2. Company Snapshot

9.18.3. Financial Overview

9.18.4. Product Listing

9.18.5. Entropy

9.19. MED-EL Medical Electronics

9.19.1. Company Overview

9.19.2. Company Snapshot

9.14.3. Financial Overview

9.19.4. Product Listing

9.19.5. Entropy

9.20. Aetna Inc.

9.20.1. Company Overview

9.20.2. Company Snapshot

9.20.3. Financial Overview

9.20.4. Product Listing

9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Table

Table 1: Competitive Analysis

Table 2: COVID-19 Impact Analysis on Ocular Implants Market

Table 3: Ocular Implants Market in Global (2019-2027)

Table 4: Ocular Implants Market in Global by Type (2019-2027)

Table 5: Ocular Implants Market in Global by Material (2019-2027)

Table 6: Ocular Implants Market in Global by Application (2019-2027)

Table 7: Ocular Implants Market in Global by End User (2019-2027)

Table 8: Ocular Implants Market in Global by Geography (2019-2027)

Table 9: Ocular Implants Market in North America (2019-2027)

Table 10: Ocular Implants Market in North America by Country (2019-2027)

Table 11: Ocular Implants Market in the US (2019-2027)

Table 12: Ocular Implants Market in Canada (2019-2027)

Table 13: Ocular Implants Market in Mexico (2019-2027)

Table 14: Ocular Implants Market in Europe (2019-2027)

Table 15: Ocular Implants Market in Europe by Country (2019-2027)

Table 16: Ocular Implants Market in France (2019-2027)

Table 17: Ocular Implants Market in Germany (2019-2027)

Table 18: Ocular Implants Market in the United Kingdom (2019-2027)

Table 19: Ocular Implants Market in Italy (2019-2027)

Table 20: Ocular Implants Market in Spain (2019-2027)

Table 21: Ocular Implants Market in Russia (2019-2027)

Table 22: Ocular Implants Market in Rest of Europe (2019-2027)

Table 23: Ocular Implants Market in APAC (2019-2027)

Table 24: Ocular Implants Market in APAC by Country (2019-2027)

Table 25: Ocular Implants Market in China (2019-2027)

Table 26: Ocular Implants Market in Japan (2019-2027)

Table 27: Ocular Implants Market in India (2019-2027)

Table 28: Ocular Implants Market in Australia (2019-2027)

Table 29: Ocular Implants Market in South Korea (2019-2027)

Table 30: Ocular Implants Market in Rest of APAC (2019-2027)

Table 31: Ocular Implants Market in Rest of World (2019-2027)

Table 32: Ocular Implants Market in RoW by Region (2019-2027)

Table 33: Ocular Implants Market in Middle East (2019-2027)

Table 34: Ocular Implants Market in Africa (2019-2027)

Table 35: Ocular Implants Market in South America (2019-2027)

List of Figures

Figure 1: Competitive Analysis

Figure 2: COVID-19 Impact Analysis on Ocular Implants Market

Figure 3: Ocular Implants Market in Global (2019-2027)

Figure 4: Ocular Implants Market in Global by Type (2019-2027)

Figure 5: Ocular Implants Market in Global by Material (2019-2027)

Figure 6: Ocular Implants Market in Global by Application (2019-2027)

Figure 7: Ocular Implants Market in Global by End User (2019-2027)

Figure 8: Ocular Implants Market in Global by Geography (2019-2027)

Figure 9: Ocular Implants Market in North America (2019-2027)

Figure 10: Ocular Implants Market in North America by Country (2019-2027)

Figure 11: Ocular Implants Market in the US (2019-2027)

Figure 12: Ocular Implants Market in Canada (2019-2027)

Figure 13: Ocular Implants Market in Mexico (2019-2027)

Figure 14: Ocular Implants Market in Europe (2019-2027)

Figure 15: Ocular Implants Market in Europe by Country (2019-2027)

Figure 16: Ocular Implants Market in France (2019-2027)

Figure 17: Ocular Implants Market in Germany (2019-2027)

Figure 18: Ocular Implants Market in the United Kingdom (2019-2027)

Figure 19: Ocular Implants Market in Italy (2019-2027)

Figure 20: Ocular Implants Market in Spain (2019-2027)

Figure 21: Ocular Implants Market in Russia (2019-2027)

Figure 22: Ocular Implants Market in Rest of Europe (2019-2027)

Figure 23: Ocular Implants Market in APAC (2019-2027)

Figure 24: Ocular Implants Market in APAC by Country (2019-2027)

Figure 25: Ocular Implants Market in China (2019-2027)

Figure 26: Ocular Implants Market in Japan (2019-2027)

Figure 27: Ocular Implants Market in India (2019-2027)

Figure 28: Ocular Implants Market in Australia (2019-2027)

Figure 29: Ocular Implants Market in South Korea (2019-2027)

Figure 30: Ocular Implants Market in Rest of APAC (2019-2027)

Figure 31: Ocular Implants Market in Rest of World (2019-2027)

Figure 32: Ocular Implants Market in RoW by Region (2019-2027)

Figure 33: Ocular Implants Market in Middle East (2019-2027)

Figure 34: Ocular Implants Market in Africa (2019-2027)

Figure 35: Ocular Implants Market in South America (2019-2027)

Figure 36: Ocular Implants Market Drivers

Figure 37: Ocular Implants Market Barriers

Figure 38: Ocular Implants Market Opportunities

Figure 39: PORTER'S Five Force Analysis

• Alcon
• Johnson & Johnson Services Inc.
• Bausch Health Companies Inc.
• ZEISS International
• STAAR SURGICAL
• Hoya Corporation
• Glaukos Corporation
• Second Sight
• AbbVie Inc.
• Innolens
• SAV-IOL SA
• Morcher
• Ophtec BV
• Novartis International AG
• NVision Eye Centres
• iSTAR Medical
• SMR Ophthalmic Pvt Ltd
• Gulden Ophthalmics
• MED-EL Medical Electronics
• Aetna Inc

 

Forward to Friend

Need A Quote